Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PK and Safety of SB204 Gel in Acne Vulgaris
NCT02164084Phase 1Completed
- Sponsor
- Novan
- Start
- Jun 2014
- Primary completion
- Jun 2014
- Modality
- Polymer-based Nanoparticles, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial in acne vulgaris comparing SB204 with Vehicle Gel (2 arms). Primary endpoints: Pharmacokinetics of nitrate at Day 5 and Pharmacokinetics of silicon at Day 5. Started Jun 2014; status: completed.
02
Drugs
berdazimer
03
Conditions
acne vulgaris
Beyond the preview
Go deeper on NCT02164084.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02164084.